Formulary updates effective Jan. 1, 2026
Dec. 2025Pharmacy Updates
Please be aware as of January 2026, there will be updates impacting formularies for all lines of business, coverage of adalimumab products, coverage of continuous glucose monitors (CGM), and billing processes for hyaluronate intra-articular injections and select intravenous and subcutaneous products. Please review the full details that include additional information on each change.
Recent Announcements
Asymptomatic Severe Coronary Disease: Detection to Decisions. Do We Know The Proper Management?
In this new CME course, Krishna V. Tummalapalli, MD, interventional cardiologist, UPMC Heart and Vascular Institute, discusses how to explain the importance of early detection of coronary artery disease, as well as how to describe how early identification can reduce future cardiovascular events and identify appropriate first line medical therapy strategies for patients with asymptomatic stable ischemic heart disease.Mar. 2026Education/Webinars
CME Webinar Series: Introducing Physicians and their teams to Value-Based Health Care
Please join us for a new CME-accredited webinar series on value-based care. This series is designed to introduce practicing physicians and their teams to value-based health care. Over the course of six sessions, we will define the components of value and identify the tools necessary to deliver high-value care for a population.Feb. 2026Education/Webinars